Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(-1)) delivered for 10 days at therapeutic dose.
Thromb Haemost
; 79(2): 338-41, 1998 Feb.
Article
in En
| MEDLINE
| ID: mdl-9493587
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thrombophlebitis
/
Nadroparin
/
Factor Xa Inhibitors
/
Anticoagulants
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Humans
Language:
En
Journal:
Thromb Haemost
Year:
1998
Document type:
Article
Affiliation country:
France
Country of publication:
Germany